Interestingly, while administration of L-NAME immediately prior to challenge did not impact the sepsis-induced reduction in serum Ang1 levels, the corresponding increase in serum Ang2 concentration was completely absent in challenged mice that received L-NAME. This evidence concerns the gene ANGPT1 and Sepsis.